Richard Dubinsky

Summary

Publications

  1. ncbi request reprint CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease
    Richard Dubinsky
    Department of Neurology, University of Kansas Medical Center, Kansas City, 66160, USA
    Mov Disord 21:530-3. 2006
  2. ncbi request reprint Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample
    Richard Dubinsky
    University of Kansas Medical Center, Department of Neurology, Kansas City, KS 66160, USA
    Neurology 66:1742-4. 2006
  3. ncbi request reprint Trends in hospital utilization and outcome for patients with ALS: analysis of a large U.S. cohort
    Richard Dubinsky
    Department of Neurology, University of Kansas Medical Center, Mail Stop 2012, 3599 Rainbow Blvd, Kansas City, KS 66160, USA
    Neurology 67:777-80. 2006
  4. ncbi request reprint Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US
    Richard M Dubinsky
    Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Neurology 68:195-7. 2007
  5. ncbi request reprint No going home for hospitalized Huntington's disease patients
    Richard M Dubinsky
    Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Mov Disord 20:1316-22. 2005

Collaborators

Detail Information

Publications5

  1. ncbi request reprint CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease
    Richard Dubinsky
    Department of Neurology, University of Kansas Medical Center, Kansas City, 66160, USA
    Mov Disord 21:530-3. 2006
    ..We conclude that, at a dose of 20 mg/kg per day, cysteamine was tolerable in people with Huntington's disease. Nausea and motoric impairment were the dose-limiting side effects...
  2. ncbi request reprint Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample
    Richard Dubinsky
    University of Kansas Medical Center, Department of Neurology, Kansas City, KS 66160, USA
    Neurology 66:1742-4. 2006
    ..1% vs 5.8%) as was the rate of secondary intracranial hemorrhage (4.2% vs 0.4%). US community experience in the use of thrombolysis has higher rates of complications and mortality than in controlled clinical trials...
  3. ncbi request reprint Trends in hospital utilization and outcome for patients with ALS: analysis of a large U.S. cohort
    Richard Dubinsky
    Department of Neurology, University of Kansas Medical Center, Mail Stop 2012, 3599 Rainbow Blvd, Kansas City, KS 66160, USA
    Neurology 67:777-80. 2006
    ..To examine hospital mortality, utilization, and trends in care of patients with ALS in a large U.S. cohort...
  4. ncbi request reprint Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US
    Richard M Dubinsky
    Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA
    Neurology 68:195-7. 2007
    ..38 (95% CI 1.27 to 1.50) vs CABG. With the increase in postoperative stroke and death, a randomized, controlled clinical trial of combined CEA-CABG is indicated...
  5. ncbi request reprint No going home for hospitalized Huntington's disease patients
    Richard M Dubinsky
    Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Mov Disord 20:1316-22. 2005
    ..With 60.31% of the discharges representing new LTCF admissions, this finding shows that there is no going home from the hospital for people with HD...